Postersession 5
Gewebezubereitungen | IT und Automatisierung in der Transfusionsmedizin | COVID-19 | Versorgungsforschung

Programme

• 16:30 – 16:35 3 Min. 2 Min.

  • Poster
  • PS-5-1

  Allografts: Expanding the clinician's armamentarium

  • Volker Eras (Berlin / DE)

   14. Gewebezubereitungen
• 16:40 – 16:45 3 Min. 2 Min.

  • Poster
  • PS-5-5

  Meeting the demands for bone allografts: challenges during COVID-19 pandemic

  • Dr. Beate Wagner (Innsbruck / AT)

   14. Gewebezubereitungen, 16. Rechtliche Grundlagen, Qualitätssicherung und regulatorische Aspekte
• 16:45 – 16:50 3 Min. 2 Min.

  • Poster
  • PS-5-6

  AutoPiLoT – Automated guideline-compliant patient-specific blood product allocation and innovative logistics management in transfusion medicine

  • Christian Martin Brieske (Essen / DE)

   17. IT und Automatisierung in der Transfusionsmedizin, 2. Versorgungsforschung
• 16:55 – 17:00 3 Min. 2 Min.

  • Poster
  • PS-5-8

  Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies between June 2020 and April 2022 in Tyrolean blood donors

  • Mag.pharm. PhD Anita Siller (Innsbruck / AT)

   19. COVID-19, 5. Infektionssicherheit von Blutprodukten
• 17:00 – 17:05 3 Min. 2 Min.

  • Poster
  • PS-5-9

  Detection of SARS-CoV-2 Spike-Protein-Specific Antibodies after Vaccination via Nasal and Buccal Swabs: Prospects for Mass Scale Immunity-Screening in Large Populations

  • Prof. Hubert Schrezenmeier (Ulm / DE)

   19. COVID-19
• 17:05 – 17:10 3 Min. 2 Min.

  • Poster
  • PS-5-10

  Immunoadsorption as a method of antibody donation during the Covid-19 pandemic

  • Jannik Rothenburg (Bremen / DE)

   19. COVID-19, 4. Präparative und Therapeutische Apherese
• 17:10 – 17:15 3 Min. 2 Min.

  • Poster
  • PS-5-11

  Increase in SARS-CoV-2 antibody titres in a normal human immunoglobulin preparation for intravenous use

  • Dr. Matthias Germer (Dreieich / DE)

   13. Neue Blutprodukte – Neue Anwendungen, 19. COVID-19
• 17:15 – 17:20 3 Min. 2 Min.

  • Poster
  • PS-5-12

  Hematopoietic stem cells from SARS-CoV-2 infected donors. Is there a risk for transmission?

  • PD Dr. Gero Hütter (Dresden / DE)

   19. COVID-19, 5. Infektionssicherheit von Blutprodukten
• 17:20 – 17:25 3 Min. 2 Min.

  • Poster
  • PS-5-13

  Patient supply with convalescent plasma at a university hospital during the first two pandemic waves

  • PD Dr. med. Robert Offner (Regensburg / DE)

   19. COVID-19
• 17:25 – 17:30 3 Min. 2 Min.

  • Poster
  • PS-5-14

  Correlation between infection severity and antibody levels in COVID-19 convalescent plasma donors

  • Dr. med. Günalp Uzun (Tübingen / DE)

   13. Neue Blutprodukte – Neue Anwendungen, 19. COVID-19
• 17:30 – 17:35 3 Min. 2 Min.

  • Poster
  • PS-5-15

  Vaccine side effects after first, second and booster vaccination against SARS-CoV-2: Data from TüSeRe:exact study

  • Alan Bareiß (Tübingen / DE)

   19. COVID-19, 5. Infektionssicherheit von Blutprodukten
• 17:35 – 17:40 3 Min. 2 Min.

  • Poster
  • PS-5-16

  Results of nanopore sequencing of  SARS-CoV-2 isolates of over a year

  • Dr.rer.nat. Marita Führer (Ulm / DE)

   18. Zukunftsgebiete der Transfusionsmedizin, 19. COVID-19
• 17:40 – 17:45 3 Min. 2 Min.

  • Poster
  • PS-5-17

  BNT162b2 booster vaccination elicits cross-reactive immunity against SARS-CoV-2 variants B.1.1.529 and B.1.617.2 in convalescents of all ages

  • Janina Hägele (Ulm / DE)

   18. Zukunftsgebiete der Transfusionsmedizin, 19. COVID-19
• 17:45 – 17:50 3 Min. 2 Min.

  • Poster
  • PS-5-18

  Effects of the COVID-19 pandemic on blood product management in a University Hospital blood bank

  • Marion Posset (Regensburg / DE)

   19. COVID-19, 2. Versorgungsforschung